The Changing Face of Cytokines in the Brain: Perspectives From EAE

Title: The Changing Face of Cytokines in the Brain: Perspectives From EAE

Volume: 11 Issue: 8

Author(s): R. D. Wheeler and T. Owens

Affiliation:

Keywords: interferon gamma, interleukin 23, experimental autoimmune encephalomyelitis

Abstract: There has been a significant increase in the number of cytokines known to exist, over the past few years. This has led to a re-examination of the established roles of cytokines, as the functions of newly identified members are characterized. In this review, we describe how the recent discovery and characterization of interleukin (IL) -23 has led to a re-evaluation of the role of interferon (IFN) γ and IFNγ-inducing factors in experimental autoimmune encephalomyelitis (EAE). Recent studies suggest that IFNg-secreting T cells, considered the hallmark of EAE, may not be the major detrimental effector cell, and may even have a regulatory function. The impact of this on current understanding of cytokine networks underlying CNS inflammation in EAE is discussed.

Cite this article as:

Wheeler D. R. and Owens T., The Changing Face of Cytokines in the Brain: Perspectives From EAE, Current Pharmaceutical Design 2005; 11 (8) . https://dx.doi.org/10.2174/1381612053381657